Strategic amr/health ec/de-linkage
I provide extensive consultancy, project design and implementation. I lead the successful application of a novel antimicrobial in the world's first de-linkage model at Pfizer and work with a number of pharma/tech/d/nonprofits to realise change
Extensive experience and connection in field of AMR and policy
Technology:
Microorganisms:
Application:
Development stage:
- Infection prevention
- Antimicrobial stewardship
- Microbial diagnostics
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Fungi
- Viruses
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Development
- Market entry
- Research
- Validation
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Company
- Academia
- Institute
- NGO
- Government
Partnering:
- Co-develop
- Joint Venture
- License
- Outsource
- Sell
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- STI
- BSI
- RTI
- GII
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
N.A.
Healthcare strategy consultancy, AMR/DATA/PATHWAYS
Clinical background as a surgeon, GP and pharmacist
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!